Clinical Trial Update: Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5% [NA]

View source ↗

Summary

A completed clinical trial evaluating tolerability and toxicity of topically applied nepafenac 0.3% compared with ketorolac 0.5% in patients undergoing cataract…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Ketorolac (Ketorolac tromethamine)
• Nepafenac (nepafenac)

Snippet

Sponsor: MDbackline, LLC | Conditions: Cataract | NA | Status: COMPLETED